Characterization of methotrexate transport and its drug interactions with human organic anion transporters.

Article Details

Citation

Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H

Characterization of methotrexate transport and its drug interactions with human organic anion transporters.

J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.

PubMed ID
12130730 [ View in PubMed
]
Abstract

Life-threatening drug interactions are known to occur between methotrexate and nonsteroidal anti-inflammatory drugs (NSAIDs), probenecid, and penicillin G. The purpose of this study was to characterize methotrexate transport, as well as to determine the site and the mechanism of drug interactions in the proximal tubule. Mouse proximal tubule cells stably expressing basolateral human organic anion transporters (hOAT1 and hOAT3) and apical hOAT (hOAT4) were established. The K(m) values for hOAT1-, hOAT3-, and hOAT4-mediated methotrexate uptake were 553.8 microM, 21.1 microM, and 17.8 microM, respectively. NSAIDs (salicylate, ibuprofen, ketoprofen, phenylbutazone, piroxicam, and indomethacin), probenecid, and penicillin G dose dependently inhibited methotrexate uptake mediated by hOAT1, hOAT3, and hOAT4. Kinetic analysis of inhibitory effects of these drugs on hOAT3-mediated methotrexate uptake revealed that these inhibitions were competitive. The K(i) values for the effects of salicylate, phenylbutazone, indomethacin, and probenecid on hOAT3-mediated methotrexate uptake were comparable with therapeutically relevant plasma concentrations of unbound drugs. In addition, in the presence of human serum albumin, the K(i) values were comparable with therapeutically relevant total plasma concentrations of drugs. In conclusion, these results suggest that methotrexate is taken up via hOAT3 and hOAT1 at the basolateral side of the proximal tubule and effluxed or taken up at the apical side via hOAT4. In addition, hOAT1, hOAT3, and hOAT4 are the sites of drug interactions between methotrexate and NSAIDs, probenecid, and penicillin G. Furthermore, it was predicted that hOAT3 is the site of drug interactions between methotrexate and salicylate, phenylbutazone, indomethacin, and probenecid in vivo.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
BenzylpenicillinSolute carrier family 22 member 8ProteinHumans
Unknown
Substrate
Inhibitor
Details
ProbenecidSolute carrier family 22 member 11ProteinHumans
Yes
Inhibitor
Details
ProbenecidSolute carrier family 22 member 6ProteinHumans
Yes
Inhibitor
Details
ProbenecidSolute carrier family 22 member 8ProteinHumans
Yes
Inhibitor
Details
Drug Transporters
DrugTransporterKindOrganismPharmacological ActionActions
BenzylpenicillinSolute carrier family 22 member 11ProteinHumans
Unknown
Inhibitor
Details
BenzylpenicillinSolute carrier family 22 member 6ProteinHumans
Unknown
Inhibitor
Details
BenzylpenicillinSolute carrier family 22 member 8ProteinHumans
Unknown
Substrate
Inhibitor
Details
DexibuprofenSolute carrier family 22 member 11ProteinHumans
Unknown
Not AvailableDetails
DexibuprofenSolute carrier family 22 member 6ProteinHumans
Unknown
Not AvailableDetails
DexibuprofenSolute carrier family 22 member 8ProteinHumans
Unknown
Not AvailableDetails
IbuprofenSolute carrier family 22 member 11ProteinHumans
Unknown
Inhibitor
Details
IbuprofenSolute carrier family 22 member 6ProteinHumans
Unknown
Inhibitor
Details
IbuprofenSolute carrier family 22 member 8ProteinHumans
Unknown
Inhibitor
Details
IndomethacinSolute carrier family 22 member 11ProteinHumans
Unknown
Inhibitor
Details
IndomethacinSolute carrier family 22 member 6ProteinHumans
Unknown
Substrate
Inhibitor
Details
IndomethacinSolute carrier family 22 member 8ProteinHumans
Unknown
Inhibitor
Details
KetoprofenSolute carrier family 22 member 11ProteinHumans
Unknown
Inhibitor
Details
KetoprofenSolute carrier family 22 member 6ProteinHumans
Unknown
Inhibitor
Details
KetoprofenSolute carrier family 22 member 7ProteinHumans
Unknown
Inhibitor
Details
KetoprofenSolute carrier family 22 member 8ProteinHumans
Unknown
Inhibitor
Details
MethotrexateSolute carrier family 22 member 11ProteinHumans
Unknown
Substrate
Details
MethotrexateSolute carrier family 22 member 6ProteinHumans
Unknown
Substrate
Inhibitor
Details
MethotrexateSolute carrier family 22 member 8ProteinHumans
Unknown
Substrate
Inhibitor
Details
PhenylbutazoneSolute carrier family 22 member 11ProteinHumans
Unknown
Inhibitor
Details
PhenylbutazoneSolute carrier family 22 member 6ProteinHumans
Unknown
Inhibitor
Details
PhenylbutazoneSolute carrier family 22 member 8ProteinHumans
Unknown
Inhibitor
Details
PiroxicamSolute carrier family 22 member 11ProteinHumans
Unknown
Inhibitor
Details
PiroxicamSolute carrier family 22 member 6ProteinHumans
Unknown
Inhibitor
Details
PiroxicamSolute carrier family 22 member 8ProteinHumans
Unknown
Inhibitor
Details
ProbenecidSolute carrier family 22 member 11ProteinHumans
Unknown
Inhibitor
Details
ProbenecidSolute carrier family 22 member 6ProteinHumans
Unknown
Substrate
Inhibitor
Details
ProbenecidSolute carrier family 22 member 8ProteinHumans
Unknown
Inhibitor
Details
Salicylic acidSolute carrier family 22 member 6ProteinHumans
Unknown
Inhibitor
Details
Salicylic acidSolute carrier family 22 member 8ProteinHumans
Unknown
Inhibitor
Details
Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
BenzylpenicillinSolute carrier family 22 member 8Ki (nM)97600N/AN/ADetails
IbuprofenSolute carrier family 22 member 8Ki (nM)1170000N/AN/ADetails
IndomethacinSolute carrier family 22 member 8Ki (nM)5950N/AN/ADetails
KetoprofenSolute carrier family 22 member 8Ki (nM)1160000N/AN/ADetails
PhenylbutazoneSolute carrier family 22 member 8Ki (nM)34700N/AN/ADetails
PiroxicamSolute carrier family 22 member 8Ki (nM)1200000N/AN/ADetails
ProbenecidSolute carrier family 22 member 8Ki (nM)29800N/AN/ADetails
Salicylic acidSolute carrier family 22 member 8Ki (nM)1020000N/AN/ADetails